Alhamadani, I., M. Alzyadi, and M. Majeed. “Prognostic Significance of the CXCL11/CXCL9/CD163 Immune Signature in Triple-Negative Breast Cancer: A Bioinformatics and Survival Analysis: CXCL11/CXCL9 Prognostic Value”. Archives of Breast Cancer, vol. 13, no. 2, Apr. 2026, pp. 154-65, doi:10.32768/abc.6274819305-647.